Raj Denhoy
Stock Analyst at Jefferies
(2.96)
# 1,192
Out of 5,182 analysts
46
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $93.86 | +27.85% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $82.28 | +58.00% | 10 | Jul 30, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.69 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $59.32 | -47.32% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $41.99 | -16.65% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $135.52 | +117.68% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $61.29 | +48.47% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $83.55 | -67.68% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $182.87 | -63.36% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $93.86
Upside: +27.85%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $82.28
Upside: +58.00%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.69
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $59.32
Upside: -47.32%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $41.99
Upside: -16.65%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $135.52
Upside: +117.68%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $61.29
Upside: +48.47%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $83.55
Upside: -67.68%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $182.87
Upside: -63.36%